Elucid Raises $27 Million Series B Funding Round Elucid Raises $27 Million Series B Funding Round to Commercialize a New Paradigm in Heart Disease Diagnosis BOSTON, June 22, 2022...
KT Corporation and Hanmi Pharmaceutical promote business cooperation with Digital PharmKT Corporation and Hanmi Pharmaceutical promote business cooperation with Digital Pharm, a Korean company specializing in digital...
UCLA Researchers Receive NIH Grant to Conduct a Multicenter Trial of eTNS for Pediatric ADHDDouble-blind randomized controlled trial will enroll up to 225 children at UCLA and Seattle Children’s Hospital NeuroSigma will provide...